Getting your Trinity Audio player ready...
|
There were a number of stocks that had come on to the radars of investors in a big way on Monday and one of those was Ra Medical Systems Inc (NYSEAMERICAN:RMED).
The stock witnesses 10 times the average trading volume and ended up with gains of as much as 4.5%.
The company announced yesterday that Catheter Precision Inc, its fully owned subsidiary unit, finally had its first customer Heart Hospital of New Mexico at Lovelace Medical Center to have concluded a total of 100 ventricular ablation procedures with the aid of VIVO.
VIVA is a non-invasive 3D imaging system that helps in the identification of the earliest electrical activation of a ventricular arrhythmia.
The interim Chief Executive Officer of Ra Medical David Jenkins spoke about the matter as well. He noted that it was a major new milestone for Catheter Precision. He went on to state that he believed that more and more hospitals and physicians were going to find value in VIVO. The fact that a hospital used this product to this degree in such a short period was also a demonstration of the benefits that were provided by the product.
It also proved that the benefits of the product were being seen and the strategies of utilization devised by the company were also working.
Dr. Sean Mazer, who is a clinical Electrophysiologist at the Heart Hospital of New Mexico and the president of the New Mexico Heart Institute/Lovelace Medical Group also spoke about the matter. He stated that the hospital had implemented VIVO in all the PVC ablations. It had helped in speeding up and improving the nature of the workflow for some of the most complicated procedures that the hospital offers.
It remains to be seen if the stock continues to add to its gains today.